Is It Too Late To Consider Aegon (ENXTAM:AGN) After A 34% One Year Gain?

• Wondering if Aegon is still reasonably priced or if the easy gains are behind it? This article walks through what the current share price might imply about value.
• The stock last closed at €6.78, with returns of 6.4% over 7 days, 13.1% over 30 days, 2.2% year to date and 34.3% over 1 year. This naturally raises questions about how much optimism is already in the price.
• Recent coverage around Aegon has focused on its positioning within the insurance sector and how investors are weighing company specific developments against broader market conditions. That context matters because it can influence whether current pricing reflects fundamentals or changing risk perceptions.
• Aegon currently has a value score of 5 out of 6. The rest of this article looks at how different valuation methods arrive at that result and also points to a richer way to think about value that comes at the end.

Aegon delivered 34.3% returns over the last year. See how this stacks up to the rest of the Insurance industry.

Approach 1: Aegon Excess Returns Analysis

The Excess Returns model looks at how efficiently Aegon uses shareholders’ equity and whether those returns are above the required cost of equity. In simple terms, it asks how much value the company might create for you after covering what investors expect to earn for the risk they take.

For Aegon, the starting Book Value is €4.98 per share, with a Stable Book Value estimate of €6.16 per share, based on forecasts from 7 analysts. The model uses a Stable EPS of €0.93 per share, sourced from weighted future Return on Equity estimates from 8 analysts, against a Cost of Equity of €0.33 per share. That leaves an Excess Return of €0.60 per share on an Average Return on Equity of 15.15%.

Putting these pieces together, the Excess Returns valuation arrives at an estimated intrinsic value of €23.77 per share. Compared with the recent share price of €6.78, this suggests the stock is 71.5% undervalued using this framework.

Result: UNDERVALUED

Our Excess Returns analysis suggests Aegon is undervalued by 71.5%. Track this in your watchlist or portfolio, or discover 226 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Aegon.

Approach 2: Aegon Price vs Earnings

For a profitable company like Aegon, the P/E ratio is a useful yardstick because it links the share price directly to the earnings that support it. Investors typically look for a P/E that lines up with what they think is a reasonable balance between expected earnings growth and the risks around those earnings.

A higher growth outlook or lower perceived risk usually justifies a higher P/E, while slower growth or higher risk tends to point to a lower "normal" range. Right now, Aegon trades on a P/E of 11.10x, compared with the Insurance industry average of about 11.97x and a peer average of 17.27x.

Simply Wall St also calculates a proprietary "Fair Ratio" for Aegon of 15.02x. This is intended to estimate the P/E that might make sense given the company’s earnings profile, industry, profit margins, market cap and risk characteristics. This makes it more tailored than a simple comparison with peers or the broad industry, which may have very different growth and risk profiles. When compared with this Fair Ratio, Aegon’s current 11.10x P/E is lower, which indicates that the shares may be undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 97 top founder-led companies.

Upgrade Your Decision Making: Choose your Aegon Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St’s Community page let you turn your view of Aegon into a clear story that links its business direction to a financial forecast and then to a fair value. You might, for example, lean toward a higher €8.60 fair value if you think its U.S. expansion, digital focus and capital light shift support stronger earnings over time. Alternatively, you might sit closer to €6.50 if you are more focused on risks around regulation, execution and legacy lines. As new news, earnings or guidance arrive, these Narratives refresh so you can quickly compare updated Fair Value ranges with the current share price to help consider whether the stock appears closer to your buy, hold or sell zone.

Do you think there's more to the story for Aegon? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com